A staggering 1.3 billion people worldwide battled metabolic dysfunction-associated steatotic liver disease (MASLD) in 2023, a 143% surge since 1990. Projections indicate this figure could reach 1.8 billion by 2050, fueled by obesity and lifestyle shifts.